Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure

Severe heart failure represents a major source of morbidity and mortality. Poor right ventricular function is an independent prognostic marker for mortality in patients with chronic heart failure. In this study, levosimendan (L) and dobutamine (D) in patients with severe chronic biventricular failure were compared. Forty consecutive patients, who were judged for inotropic therapy by their primary physicians, with acutely decompensated systolic heart failure and having moderate-to-severe right ventricular dysfunction with right ventricular fractional area change of

show abstract

Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure

Yılmaz

Yontar

Erdem

et al. 2009

Heart Vessels

View full text Add to dashboard Cite

show abstract

Nitroprusside in decompensated heart failure: What should a clinician really know?

Opasich

Cioffi

Gualco

2009

Curr Heart Fail Rep

View full text Add to dashboard Cite

Sodium nitroprusside is an older intravenous vasodilator appropriate for acute hospital treatment of patients with congestive heart failure. It is a balanced arterial and venous vasodilator with a very short half-life, facilitating rapid titration. In general, it improves hemodynamic and clinical status by reducing systemic vascular resistance, left ventricular filling pressure, and increasing cardiac output. This review summarizes recently published literature and recent data regarding the use of this intravenous vasodilator in decompensated heart failure patients.

show abstract

Effect of Different Pharmacologic Agents to Reverse Severe Pulmonary Hypertension Among End-Stage Heart Failure Patients

Macho

Jiménez

Salvo

et al. 2009

Transplantation Proceedings

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure

Cited by 12 publications

References 15 publications

Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure

Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure

Nitroprusside in decompensated heart failure: What should a clinician really know?

Effect of Different Pharmacologic Agents to Reverse Severe Pulmonary Hypertension Among End-Stage Heart Failure Patients

Contact Info

Product

Resources

About